Category

• Pipeline1
• Products1
• Research1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Eye Drop Solution2
• Glance Videos1
• Acquisitions1
• Eye Drops1
• Gene Therapy1
• Inherited Retinal Disease1
• Licensing Agreement1
• Ophthalmology1
• Presbyopia1
• Presbyopia Eye Drops1

• Organizations: Laboratoires Théa✕

Clear all

Pipeline

LENZ and Théa partner on Canadian commercialization of presbyopia eye drop

Licensing and commercialization agreement gives LENZ $70 million in upfront and milestone payments; news comes as company awaits FDA approval.

Research

Preservative Freedom Coalition is targeting ocular surface awareness

Launched by Théa Pharma, the organization advocates for improved patient outcomes and ensuring access to safe and effective preservative-free treatment options.

Products

Laboratoires Théa purchases ProQR Therapeutics' IRD RNA therapies

Sepofarsen and ulevursen target underlying vision loss in LCA10 and Usher syndrome.